<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 13 Jul 2026 17:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4/A        Perimeter Solutions,      For: Jun 26  Filed by: Amin Snehal</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+Amin+Snehal/26763338.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26763338.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+Amin+Snehal/26763338.html</guid>
   <pubDate>Mon, 13 Jul 2026 17:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>Form  4/A        Perimeter Solutions,      For: Jun 26  Filed by: Amin Snehal</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+Amin+Snehal/26763338.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26763338.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+Amin+Snehal/26763338.html</guid>
   <pubDate>Mon, 13 Jul 2026 17:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR launches Allyntra, a precision-engineered medtech platform</title>
   <link>http://www.streetinsider.com/Corporate+News/KKR+launches+Allyntra%2C+a+precision-engineered+medtech+platform/26749858.html</link>
   <description>&lt;p&gt;KKR (NYSE: KKR) has launched Allyntra, a newly formed precision-engineered solutions platform focused on medical technology and other precision end markets, according to a press release from the company.&lt;/p&gt;&lt;p&gt;The platform builds on KKR's existing investment in Precipart, made through its Health Care Strategic Growth Fund II, with Precipart serving as a foundational business within the new entity. KKR said it is committing additional capital to support Allyntra's growth through acquisitions and continued investment.&lt;/p&gt;&lt;p&gt;Robbie Atkinson has been appointed Chief Executive Officer of Allyntra and Brian Highley as Chairman. Atkinson previously served as CEO and President of Medical Manufacturing Technologies, where he</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/KKR+launches+Allyntra%2C+a+precision-engineered+medtech+platform/26749858.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR launches Allyntra, a precision-engineered medtech platform</title>
   <link>http://www.streetinsider.com/Corporate+News/KKR+launches+Allyntra%2C+a+precision-engineered+medtech+platform/26749858.html</link>
   <description>&lt;p&gt;KKR (NYSE: KKR) has launched Allyntra, a newly formed precision-engineered solutions platform focused on medical technology and other precision end markets, according to a press release from the company.&lt;/p&gt;&lt;p&gt;The platform builds on KKR's existing investment in Precipart, made through its Health Care Strategic Growth Fund II, with Precipart serving as a foundational business within the new entity. KKR said it is committing additional capital to support Allyntra's growth through acquisitions and continued investment.&lt;/p&gt;&lt;p&gt;Robbie Atkinson has been appointed Chief Executive Officer of Allyntra and Brian Highley as Chairman. Atkinson previously served as CEO and President of Medical Manufacturing Technologies, where he</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/KKR+launches+Allyntra%2C+a+precision-engineered+medtech+platform/26749858.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries</title>
   <link>http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/KKR+Launches+Allyntra%2C+an+Engineered+Solutions+Platform+for+Medical+Technology+and+Precision+Industries/26749857.html</guid>
   <pubDate>Thu, 09 Jul 2026 06:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.18817746</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KKR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14891823</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26306030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>JPMorgan Starts Perimeter Solutions SA (PRM) at Overweight</title>
   <link>http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Perimeter+Solutions+SA+%28PRM%29+at+Overweight/26749047.html</link>
   <description>&lt;p&gt;JPMorgan analyst Tomohiko Sano initiates coverage on Perimeter Solutions SA (NYSE: PRM) with a Overweight rating and a price target of $50.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We are initiating coverage of Perimeter Solutions (PRM) with an Overweight rating and a $50 price target (~50% upside potential). We view Perimeter as a niche market leader in fire retardants with expanding suppressant capabilities, a disciplined M&amp;A playbook proving portable beyond fire, and a differentiated, decentralized operating structure. Perimeter’s adjusted EBITDA margin reached 50.8% in FY25A, underscoring an already high-profit base. Our management meetings and FDIC International checks reinforced an innovative, relationship driven culture, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Perimeter+Solutions+SA+%28PRM%29+at+Overweight/26749047.html</guid>
   <pubDate>Thu, 09 Jul 2026 03:16:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>JPMorgan Starts Perimeter Solutions SA (PRM) at Overweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/JPMorgan+Starts+Perimeter+Solutions+SA+%28PRM%29+at+Overweight/26749047.html</link>
   <description>&lt;p&gt;JPMorgan analyst Tomohiko Sano initiates coverage on Perimeter Solutions SA (NYSE: PRM) with a Overweight rating and a price target of $50.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We are initiating coverage of Perimeter Solutions (PRM) with an Overweight rating and a $50 price target (~50% upside potential). We view Perimeter as a niche market leader in fire retardants with expanding suppressant capabilities, a disciplined M&amp;A playbook proving portable beyond fire, and a differentiated, decentralized operating structure. Perimeter’s adjusted EBITDA margin reached 50.8% in FY25A, underscoring an already high-profit base. Our management meetings and FDIC International checks reinforced an innovative, relationship driven culture, and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/JPMorgan+Starts+Perimeter+Solutions+SA+%28PRM%29+at+Overweight/26749047.html</guid>
   <pubDate>Thu, 09 Jul 2026 03:16:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>Form  4          Perimeter Solutions,      For: Jun 26  Filed by: WINDACRE PARTNERSHIP LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+WINDACRE+PARTNERSHIP+LLC/26715208.html</link>
   <description>si-local-file:///var/storage/secattach/20260630/26715208.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+WINDACRE+PARTNERSHIP+LLC/26715208.html</guid>
   <pubDate>Tue, 30 Jun 2026 19:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>Form  4          Perimeter Solutions,      For: Jun 26  Filed by: WINDACRE PARTNERSHIP LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+WINDACRE+PARTNERSHIP+LLC/26715208.html</link>
   <description>si-local-file:///var/storage/secattach/20260630/26715208.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perimeter+Solutions%2C++++++For%3A+Jun+26++Filed+by%3A+WINDACRE+PARTNERSHIP+LLC/26715208.html</guid>
   <pubDate>Tue, 30 Jun 2026 19:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>MMT names Grant Bowman as president after Perimeter Solutions acquisition</title>
   <link>http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</link>
   <description>

&lt;p&gt;Medical Manufacturing Technologies (MMT), a subsidiary of Perimeter Solutions (NYSE: PRM), has appointed Grant Bowman as president, succeeding Robbie Atkinson, who stepped down to pursue another leadership role.&lt;/p&gt;

&lt;p&gt;Bowman previously served as Executive Vice President of Specialty Products at Perimeter Solutions, where he led strategic growth and operational initiatives. He brings more than two decades of experience in operations, finance, and business development.&lt;/p&gt;

&lt;p&gt;Atkinson had served as CEO and President of MMT since 2020. In a statement, he said, &quot;It has been a privilege to lead MMT and work alongside such an incredible team,&quot; adding that he has &quot;complete confidence in Grant's</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:01:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.39534240</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00399335</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>MMT names Grant Bowman as president after Perimeter Solutions acquisition</title>
   <link>http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</link>
   <description>

&lt;p&gt;Medical Manufacturing Technologies (MMT), a subsidiary of Perimeter Solutions (NYSE: PRM), has appointed Grant Bowman as president, succeeding Robbie Atkinson, who stepped down to pursue another leadership role.&lt;/p&gt;

&lt;p&gt;Bowman previously served as Executive Vice President of Specialty Products at Perimeter Solutions, where he led strategic growth and operational initiatives. He brings more than two decades of experience in operations, finance, and business development.&lt;/p&gt;

&lt;p&gt;Atkinson had served as CEO and President of MMT since 2020. In a statement, he said, &quot;It has been a privilege to lead MMT and work alongside such an incredible team,&quot; adding that he has &quot;complete confidence in Grant's</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:01:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.39534240</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00399335</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>MMT names Grant Bowman as president after Perimeter Solutions acquisition</title>
   <link>http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</link>
   <description>

&lt;p&gt;Medical Manufacturing Technologies (MMT), a subsidiary of Perimeter Solutions (NYSE: PRM), has appointed Grant Bowman as president, succeeding Robbie Atkinson, who stepped down to pursue another leadership role.&lt;/p&gt;

&lt;p&gt;Bowman previously served as Executive Vice President of Specialty Products at Perimeter Solutions, where he led strategic growth and operational initiatives. He brings more than two decades of experience in operations, finance, and business development.&lt;/p&gt;

&lt;p&gt;Atkinson had served as CEO and President of MMT since 2020. In a statement, he said, &quot;It has been a privilege to lead MMT and work alongside such an incredible team,&quot; adding that he has &quot;complete confidence in Grant's</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:01:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.39534240</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00399335</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>MMT names Grant Bowman as president after Perimeter Solutions acquisition</title>
   <link>http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</link>
   <description>

&lt;p&gt;Medical Manufacturing Technologies (MMT), a subsidiary of Perimeter Solutions (NYSE: PRM), has appointed Grant Bowman as president, succeeding Robbie Atkinson, who stepped down to pursue another leadership role.&lt;/p&gt;

&lt;p&gt;Bowman previously served as Executive Vice President of Specialty Products at Perimeter Solutions, where he led strategic growth and operational initiatives. He brings more than two decades of experience in operations, finance, and business development.&lt;/p&gt;

&lt;p&gt;Atkinson had served as CEO and President of MMT since 2020. In a statement, he said, &quot;It has been a privilege to lead MMT and work alongside such an incredible team,&quot; adding that he has &quot;complete confidence in Grant's</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/MMT+names+Grant+Bowman+as+president+after+Perimeter+Solutions+acquisition/26688533.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:01:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.39534240</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00399335</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
  <item>
   <title>Medical Manufacturing Technologies (MMT) Appoints Grant Bowman as President to Lead the Company's Next Chapter of Growth and Innovation</title>
   <link>http://www.streetinsider.com/Press+Releases/Medical+Manufacturing+Technologies+%28MMT%29+Appoints+Grant+Bowman+as+President+to+Lead+the+Company%27s+Next+Chapter+of+Growth+and+Innovation/26688478.html</link>
   <description>
&lt;p&gt;    CHARLOTTE, N.C.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.mmt-inc.com%2F&amp;amp;esheet=54559959&amp;amp;newsitemid=20260625252128&amp;amp;lan=en-US&amp;amp;anchor=Medical+Manufacturing+Technologies&amp;amp;index=1&amp;amp;md5=e66fd5061e2e3fd0a0d8252d8214325f&quot; shape=&quot;rect&quot;&gt;Medical Manufacturing Technologies&lt;/a&gt; (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fmmt-inc.com%2Fleadership%2F&amp;amp;esheet=54559959&amp;amp;newsitemid=20260625252128&amp;amp;lan=en-US&amp;amp;anchor=Grant+Bowman&amp;amp;index=2&amp;amp;md5=785faac556d196f1ed40cc48dea5c753&quot; shape=&quot;rect&quot;&gt;Grant Bowman&lt;/a&gt; as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medical+Manufacturing+Technologies+%28MMT%29+Appoints+Grant+Bowman+as+President+to+Lead+the+Company%27s+Next+Chapter+of+Growth+and+Innovation/26688478.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.39534240</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00399335</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50779766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRM</category>
   	  </item>
 </channel>
</rss>
